Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Acute Kidney Injury | Research article

A comparison between two different definitions of contrast-associated acute kidney injury for long-term mortality in patients with diabetes undergoing coronary angiography: a prospective cohort study

Authors: Zhubin Lun, Li Lei, Dianhua Zhou, Ming Ying, Liwei Liu, Guanzhong Chen, Jin Liu, Yibo He, Huanqiang Li, Zhidong Huang, Yongquan Yang, Jianfeng Ye, Yong Liu

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

The definitions of contrast-associated acute kidney injury (CA-AKI) are diverse and have different predictive effects for prognosis, which are adverse for clinical practice. Few articles have discussed the relationship between these definitions and long-term prognosis in patients with diabetes.

Methods

A total of 1154 diabetic patients who were undergoing coronary angiography (CAG) were included in this study. Two definitions of CA-AKI were used: CA-AKIA was defined as an increase ≥ 0.3 mg/dl or > 50% in serum creatinine (SCr) from baseline within 72 h after CAG, and CA-AKIB was defined as an increase ≥ 0.5 mg/dl or > 25% in SCr from baseline within 72 h after CAG. We used Cox regression to evaluate the association of these two CA-AKI definitions with long-term mortality and calculate the population attributable risks (PARs) of different definitions for long-term prognosis.

Results

During the median follow-up period of 7.4 (6.2–8.2) years, the overall long-term mortality was 18.84%, and the long-term mortality in patients with CA-AKI according to both CA-AKIA and CA-AKIB criteria were 36.73% and 28.86%, respectively. We found that CA-AKIA (HR: 2.349, 95% CI 1.570–3.517, p = 0.001) and CA-AKIB (HR: 1.608, 95% CI 1.106–2.339, p = 0.013) were associated with long-term mortality. The PARs were the highest for CA-AKIA (31.14%), followed by CA-AKIB (14.93%).

Conclusions

CA-AKI is a common complication in diabetic patients receiving CAG. The two CA-AKI definitions are significantly associated with a poor long-term prognosis, and CA-AKIA, with the highest PAR, needs more clinical attention.
Literature
1.
go back to reference Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150(2):330–7.CrossRef Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150(2):330–7.CrossRef
2.
go back to reference Mitchell AM, Kline JA, Jones AE, Tumlin JA. Major adverse events one year after acute kidney injury after contrast-enhanced computed tomography. Ann Emerg Med. 2015;66(3):267-74 e4.CrossRef Mitchell AM, Kline JA, Jones AE, Tumlin JA. Major adverse events one year after acute kidney injury after contrast-enhanced computed tomography. Ann Emerg Med. 2015;66(3):267-74 e4.CrossRef
3.
go back to reference Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, Tsutsui H, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study. Int J Cardiol. 2017;227:424–9.CrossRef Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, Tsutsui H, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study. Int J Cardiol. 2017;227:424–9.CrossRef
4.
go back to reference Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Ferrante G, Acquaviva R, et al. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2016;210:4–9.CrossRef Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Ferrante G, Acquaviva R, et al. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2016;210:4–9.CrossRef
5.
go back to reference Chen SQ, Liu Y, Smyth B, Li HL, Sun GL, Chen ZJ, et al. Clinical implications of contrast-induced nephropathy in patients without baseline renal dysfunction undergoing coronary angiography. Heart Lung Circ. 2019;28(6):866–73.CrossRef Chen SQ, Liu Y, Smyth B, Li HL, Sun GL, Chen ZJ, et al. Clinical implications of contrast-induced nephropathy in patients without baseline renal dysfunction undergoing coronary angiography. Heart Lung Circ. 2019;28(6):866–73.CrossRef
6.
go back to reference Lei L, Xue Y, Guo Z, Liu B, He Y, Song F, et al. A comparison between different definitions of contrast-induced acute kidney injury for long-term mortality in patients with acute myocardial infarction. Int J Cardiol Heart Vasc. 2020;28:100522.PubMedPubMedCentral Lei L, Xue Y, Guo Z, Liu B, He Y, Song F, et al. A comparison between different definitions of contrast-induced acute kidney injury for long-term mortality in patients with acute myocardial infarction. Int J Cardiol Heart Vasc. 2020;28:100522.PubMedPubMedCentral
7.
go back to reference Guillon B, Ecarnot F, Marcucci C, Ducloux D, Chatot M, Badoz M, et al. Incidence, predictors, and impact on six-month mortality of three different definitions of contrast-induced acute kidney injury after coronary angiography. Am J Cardiol. 2018;121(7):818–24.CrossRef Guillon B, Ecarnot F, Marcucci C, Ducloux D, Chatot M, Badoz M, et al. Incidence, predictors, and impact on six-month mortality of three different definitions of contrast-induced acute kidney injury after coronary angiography. Am J Cardiol. 2018;121(7):818–24.CrossRef
8.
go back to reference Akyuz S, Kemaloglu Oz T, Altay S, Karaca M, Yaylak B, Gungor B, et al. Association between glycosylated haemoglobin level and contrast-induced acute kidney injury in patients with type 2 diabetes mellitus. Cardiorenal Med. 2014;4(2):95–102.CrossRef Akyuz S, Kemaloglu Oz T, Altay S, Karaca M, Yaylak B, Gungor B, et al. Association between glycosylated haemoglobin level and contrast-induced acute kidney injury in patients with type 2 diabetes mellitus. Cardiorenal Med. 2014;4(2):95–102.CrossRef
9.
go back to reference Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc. 2014;3(6):e001380.CrossRef Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc. 2014;3(6):e001380.CrossRef
10.
go back to reference Chou RH, Huang PH, Hsu CY, Leu HB, Huang SS, Huang CC, et al. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions. J Formos Med Assoc. 2016;115(7):501–9.CrossRef Chou RH, Huang PH, Hsu CY, Leu HB, Huang SS, Huang CC, et al. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions. J Formos Med Assoc. 2016;115(7):501–9.CrossRef
11.
go back to reference Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–9.PubMed Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–9.PubMed
12.
go back to reference Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, Chen ZJ, et al. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015;8(6):e001859. Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, Chen ZJ, et al. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015;8(6):e001859.
13.
go back to reference Ad-hoc working group of E, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–72.CrossRef Ad-hoc working group of E, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–72.CrossRef
14.
go back to reference Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65(2):96–105.CrossRef Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65(2):96–105.CrossRef
15.
go back to reference Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014;383(9931):1814–23.CrossRef Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014;383(9931):1814–23.CrossRef
16.
go back to reference Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018;378(7):603–14.CrossRef Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018;378(7):603–14.CrossRef
17.
go back to reference Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
18.
go back to reference Shuvy M, Beeri G, Klein E, Cohen T, Shlomo N, Minha S, et al. Accuracy of the Global Registry of Acute Coronary Events (GRACE) risk score in contemporary treatment of patients with acute coronary syndrome. Can J Cardiol. 2018;34(12):1613–7.CrossRef Shuvy M, Beeri G, Klein E, Cohen T, Shlomo N, Minha S, et al. Accuracy of the Global Registry of Acute Coronary Events (GRACE) risk score in contemporary treatment of patients with acute coronary syndrome. Can J Cardiol. 2018;34(12):1613–7.CrossRef
19.
go back to reference Roe MT, Chen AY, Thomas L, Wang TY, Alexander KP, Hammill BG, et al. Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score. Am Heart J. 2011;162(5):875–831.CrossRef Roe MT, Chen AY, Thomas L, Wang TY, Alexander KP, Hammill BG, et al. Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score. Am Heart J. 2011;162(5):875–831.CrossRef
20.
go back to reference Chalikias G, Drosos I, Tziakas DN. Contrast-induced acute kidney injury: an update. Cardiovasc Drugs Ther. 2016;30(2):215–28.CrossRef Chalikias G, Drosos I, Tziakas DN. Contrast-induced acute kidney injury: an update. Cardiovasc Drugs Ther. 2016;30(2):215–28.CrossRef
21.
go back to reference Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–55.CrossRef Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–55.CrossRef
22.
go back to reference Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–605.CrossRef Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–605.CrossRef
23.
go back to reference Pesarini G, Lunardi M, Ederle F, Zivelonghi C, Scarsini R, Gambaro A, et al. Long-term (3 years) prognosis of contrast-induced acute kidney injury after coronary angiography. Am J Cardiol. 2016;117(11):1741–6.CrossRef Pesarini G, Lunardi M, Ederle F, Zivelonghi C, Scarsini R, Gambaro A, et al. Long-term (3 years) prognosis of contrast-induced acute kidney injury after coronary angiography. Am J Cardiol. 2016;117(11):1741–6.CrossRef
24.
go back to reference Budano C, Levis M, D’Amico M, Usmiani T, Fava A, Sbarra P, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J. 2011;161(5):963–71.CrossRef Budano C, Levis M, D’Amico M, Usmiani T, Fava A, Sbarra P, et al. Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J. 2011;161(5):963–71.CrossRef
25.
go back to reference Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26(3):287–92.CrossRef Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26(3):287–92.CrossRef
26.
go back to reference Ni Z, Liang Y, Xie N, Liu J, Sun G, Chen S, et al. Simple pre-procedure risk stratification tool for contrast-induced nephropathy. J Thorac Dis. 2019;11(4):1597–610.CrossRef Ni Z, Liang Y, Xie N, Liu J, Sun G, Chen S, et al. Simple pre-procedure risk stratification tool for contrast-induced nephropathy. J Thorac Dis. 2019;11(4):1597–610.CrossRef
27.
go back to reference Zeng JF, Chen SQ, Ye JF, Chen Y, Lei L, Liu XQ, et al. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes. Clin Exp Nephrol. 2019;23(7):969–81.CrossRef Zeng JF, Chen SQ, Ye JF, Chen Y, Lei L, Liu XQ, et al. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes. Clin Exp Nephrol. 2019;23(7):969–81.CrossRef
28.
go back to reference Zafrir B, Jaffe R, Rubinshtein R, Karkabi B, Flugelman MY, Halon DA. Impact of diabetes mellitus on long-term mortality in patients presenting for coronary angiography. Am J Cardiol. 2017;119(8):1141–5.CrossRef Zafrir B, Jaffe R, Rubinshtein R, Karkabi B, Flugelman MY, Halon DA. Impact of diabetes mellitus on long-term mortality in patients presenting for coronary angiography. Am J Cardiol. 2017;119(8):1141–5.CrossRef
29.
go back to reference Chong E, Poh KK, Liang S, Tan HC. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singap. 2010;39(5):374–80.PubMed Chong E, Poh KK, Liang S, Tan HC. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singap. 2010;39(5):374–80.PubMed
30.
go back to reference Guo XS, Lin KY, Li HL, Chen JY, Zhou YL, Liu Y, et al. Preprocedural high-sensitivity C-reactive protein predicts contrast-induced nephropathy and long-term outcome after coronary angiography. Angiology. 2017;68(7):614–20.CrossRef Guo XS, Lin KY, Li HL, Chen JY, Zhou YL, Liu Y, et al. Preprocedural high-sensitivity C-reactive protein predicts contrast-induced nephropathy and long-term outcome after coronary angiography. Angiology. 2017;68(7):614–20.CrossRef
31.
go back to reference Nemoto N, Iwasaki M, Nakanishi M, Araki T, Utsunomiya M, Hori M, et al. Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2014;113(10):1647–51.CrossRef Nemoto N, Iwasaki M, Nakanishi M, Araki T, Utsunomiya M, Hori M, et al. Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2014;113(10):1647–51.CrossRef
Metadata
Title
A comparison between two different definitions of contrast-associated acute kidney injury for long-term mortality in patients with diabetes undergoing coronary angiography: a prospective cohort study
Authors
Zhubin Lun
Li Lei
Dianhua Zhou
Ming Ying
Liwei Liu
Guanzhong Chen
Jin Liu
Yibo He
Huanqiang Li
Zhidong Huang
Yongquan Yang
Jianfeng Ye
Yong Liu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01778-6

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue